Net Vet Weekly

2 downloads 0 Views 105KB Size Report
Dwight Bowman, Cornell University; Christian Epe, Novartis Animal Health; ... of the Oklahoma State University Center for Veterinary Health Sciences.
Net Vet Weekly Week in Review:

CVHS Hosts the NCVP Advisory Board

This novel drug was approved by the FDA for type 2 diabetes therapy in humans and is proving to be a safe and effective treatment. Diabetic cats are very similar to people with type 2 diabetes and this investigational drug could prove to be equally valuable in the cats’ treatment.   

All costs related to hospital visits, examinations, diagnostics, and Dr. Susan Little, Veterinary Pathobiology, hosted the National Center for Veterinary Parasitology’s Advisory Board for their first medications will be covered by the clinical trial for the duration of the study (3 months). The management of the cat’s diabetes will meeting. The board convened to prioritize needs, develop a be at the highest standard of care. Estimated value per patient is training program, identify the research focus and determine how to meet diagnostic needs. Activities included a tour of the NCVP $1,250.   designated lab and office space, reviewing blueprints/renovation For more information, contact the Principal Investigator, Dr. Jill plans and a tour of the OSU Tick Lab. Brunker, at OSU’s Center for Veterinary Health Sciences: phone 405-744-7000; fax 405-744-7370; email [email protected].

Roof Outage Workers will be on the roof of McElroy Hall performing roof repairs and preventative maintenance on roof top equipment on Monday, May 18, from 8 a.m. until 5 p.m. Please do not use hoods vented to the roof during this time.

House Officer Seminars Dr. Sara Gresham, intern in Small Animal Medicine and Surgery, will present “Canine Malignant Melanoma and Current Therapies” on Tuesday, May 19, at 8 a.m. in Room 104 at the Teaching Hospital. Dr. Gresham’s mentor is Dr. Jill Brunker. Pictured left to right: Front row: Drs. Susan Little, OSU; Eileen Johnson, OSU; Anne Zajac, Virginia Tech; and Kathy Kocan, CVHS. Back row: Drs. Mason Reichard, OSU; Craig Reinemeyer, East Tennessee Clinical Research; Dwight Bowman, Cornell University; Christian Epe, Novartis Animal Health; Byron Blagburn, Auburn University; and Doug Hutchens, Bayer Animal Health.

Dr. Heath Qualls, resident in Equine Internal Medicine, will present “Efficacy of Adsorbents on Cantharidin Toxicosis” on Thursday, May 21, at 8 a.m. in Room 104 at the Teaching Hospital. Dr. Qualls’ mentors are Drs. Lyndi Gilliam and Todd Holbrook.

Members of the NCVP Advisory Board are:

Generator Test Schedule



Dr. Byron Blagburn, Auburn University



Dr. Dwight Bowman, Cornell University



Dr. Mike Dryden, Kansas State University



Vet Med Annex – Tuesday, May 19, at 5 p.m.



Dr. Christian Epe, Novartis Animal Health



McElroy Hall – Wednesday, May 20, at 7 a.m.



Dr. Doug Hutchens, Bayer Animal Health



Teaching Hospital – Thursday, May 21, at 7 a.m.



Dr. Susan Little, Oklahoma State University



OADDL – Thursday, May 21, at 5 p.m.



Dean Michael Lorenz, Oklahoma State University

Brief interruptions of power may be experienced during these one hour tests:



Dr. Craig Reinemeyer, East Tennessee Clinical Research



Dr. Anne Zajac, Virginia Tech

Publications Myers, S.E., LaRue, R., Shaw, D.P., Love, B.C., and Njenga, M.K. 2009. Pathogenesis of Coxsackievirus-B5 acquired from intra-renal porcine islet cell xenografts in diabetic mice. Xenotransplantation 16:91-98.

Week Ahead:

Candidate Seminar The Physiological Sciences Department will host Narendranath Chintagari, Ph.D., Physiological Sciences, OSU. Dr. Chintagari will present “Lung Surfactant Secretion: Insights into Basic Biology and Disease” on Wednesday, May 20, at 2:30 p.m. in Room 263 McElroy Hall.

Have a Safe and Happy Memorial Day Holiday Weekend!

Do You Have a Newly Diagnosed Diabetic Cat? Jill D. Brunker, DVM, Diplomate ACVIM, Small Animal Internal Medicine, Oklahoma State University Center for Veterinary Health Sciences, is looking for up to 16 newly diagnosed diabetic cats for a clinical trial using a human drug. To qualify for the study, cats must be naïve diabetics and cannot have been treated with any diabetic management modalities.  This is a publication of the Oklahoma State University Center for Veterinary Health Sciences. We welcome your comments as well as suggestions for content. Please send all feedback to Derinda Lowe, Coordinator of Public Relations and Alumni Affairs.

   -------